Literature DB >> 24890319

Restoration of adiponectin expression via the ERK pathway in TNFα-treated 3T3-L1 adipocytes.

Eugene Chang1, Jung Mook Choi1, Won Jun Kim2, Eun-Jung Rhee3, Ki Won Oh3, Won-Young Lee3, Se Eun Park3, Sung Woo Park3, Cheol-Young Park1.   

Abstract

Adiponectin and tumor necrosis factor‑α (TNF‑α) exert opposite effects on obesity‑associated inflammation and insulin signaling. The purpose of the present study was to investigate the effects of chronic TNF‑α on adiponectin levels in 3T3‑L1 adipocytes, as well as the potential reversal mechanisms. Differentiated 3T3‑L1 adipocytes were exposed to TNF‑α for three different incubation times and then to various wash‑off periods with or without mitogen‑activated protein kinase (MAPK) inhibitors. TNF‑α significantly reduced adiponectin gene expression in a dose‑ and time‑dependent manner and activated c‑Jun N‑terminal kinases (JNK), extracellular signal‑regulated kinases (ERK) and p38 MAPK. A 16 h restoration period fully reversed the decrease in adiponectin levels following 16 h treatment with TNF‑α; however, 16 h withdrawal of TNF‑α following 32 or 48 h treatment did not completely reverse the TNF‑α‑induced decrease in adiponectin levels. In 3T3‑L1 adipocytes, 32 or 48 h wash‑off periods were required following 32 or 48 h TNF‑α treatments, respectively. The pattern of ERK activation following TNF‑α exposure and removal was similar to the pattern of adiponectin expression. Furthermore, ERK1/2 inhibition accelerated the recovery of adiponectin levels compared with the levels in the untreated control adipocytes. Therefore, the inhibitory effects of TNF‑α on adiponectin levels in differentiated 3T3‑L1 cells were fully reversed following a wash‑out period equivalent to the TNF‑α treatment time, potentially through the ERK 1/2 pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24890319     DOI: 10.3892/mmr.2014.2278

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

1.  Insulin Increases Adipose Adiponectin in Pregnancy by Inhibiting Ubiquitination and Degradation: Impact of Obesity.

Authors:  Irving L M H Aye; Fredrick J Rosario; Anita Kramer; Oddrun Kristiansen; Trond M Michelsen; Theresa L Powell; Thomas Jansson
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 6.134

2.  Upregulation of adiponectin by Ginsenoside Rb1 contributes to amelioration of hepatic steatosis induced by high fat diet.

Authors:  Yaru Li; Shuchen Zhang; Ziwei Zhu; Ruonan Zhou; Pingyuan Xu; Lingyan Zhou; Yue Kan; Jiao Li; Juan Zhao; Penghua Fang; Xizhong Yu; Wenbin Shang
Journal:  J Ginseng Res       Date:  2021-11-03       Impact factor: 5.735

Review 3.  A Potential Interplay between HDLs and Adiponectin in Promoting Endothelial Dysfunction in Obesity.

Authors:  Monica Zocchi; Matteo Della Porta; Federico Lombardoni; Roberta Scrimieri; Gian Vincenzo Zuccotti; Jeanette A Maier; Roberta Cazzola
Journal:  Biomedicines       Date:  2022-06-07

4.  Modulation of adipose inflammation by cellular retinoic acid-binding protein 1.

Authors:  Chin-Wen Wei; Jennifer Nhieu; Yu-Lung Lin; Li-Na Wei
Journal:  Int J Obes (Lond)       Date:  2022-07-06       Impact factor: 5.551

Review 5.  Obesity: a perfect storm for carcinogenesis.

Authors:  Benjamin H L Harris; Valentine M Macaulay; David A Harris; Paul Klenerman; Fredrik Karpe; Simon R Lord; Adrian L Harris; Francesca M Buffa
Journal:  Cancer Metastasis Rev       Date:  2022-08-30       Impact factor: 9.237

6.  Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-Alpha.

Authors:  Emma V Morris; Karla J Suchacki; Joseph Hocking; Rachel Cartwright; Aneka Sowman; Beatriz Gamez; Ryan Lea; Matthew T Drake; William P Cawthorn; Claire M Edwards
Journal:  J Bone Miner Res       Date:  2020-01-16       Impact factor: 6.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.